Clinical interventions to break the obesity and cancer link: a narrative review

被引:0
作者
Nakul J. Bhardwaj
Kacey Chae
Jennifer Y. Sheng
Hsin-Chieh Yeh
机构
[1] Johns Hopkins School of Medicine,Department of Medicine
[2] Johns Hopkins School of Medicine,Department of Oncology
来源
Cancer and Metastasis Reviews | 2022年 / 41卷
关键词
Cancer; Obesity; Anti-obesity medication; Bariatric surgery; Weight loss;
D O I
暂无
中图分类号
学科分类号
摘要
Excess body weight is a significant risk factor for the development and recurrence of many types of cancer. Patients with a history or current diagnosis of cancer who are overweight or have obesity have an increased risk of cancer treatment-related morbidity, recurrence, and decreased quality of life. Weight loss and maintenance of a healthy body weight may reduce cancer morbidity and recurrence in cancer survivors. While guidelines for cancer survivorship elaborate sufficiently on lifestyle interventions, little guidance is provided when considering additional therapies like anti-obesity pharmacotherapy or bariatric surgery for weight loss. This review will highlight and address current recommendations and feasible interventions that clinicians may consider to further reduce the incidence and recurrence of cancer in patients with obesity.
引用
收藏
页码:719 / 735
页数:16
相关论文
共 6 条
[1]  
Rock CL(2020)American Cancer Society guideline for diet and physical activity for cancer prevention CA: A Cancer Journal for Clinicians 70 245-271
[2]  
Thomson C(2022)Effect of metformin vs placebo on invasive disease-free survival in patients with breast cancer: The MA.32 Randomized Clinical Trial JAMA - Journal of the American Medical Association 327 1963-1973
[3]  
Gansler T(undefined)undefined undefined undefined undefined-undefined
[4]  
Goodwin PJ(undefined)undefined undefined undefined undefined-undefined
[5]  
Chen BE(undefined)undefined undefined undefined undefined-undefined
[6]  
Gelmon KA(undefined)undefined undefined undefined undefined-undefined